
Pubmed-entry ::= {
  pmid 29330398,
  medent {
    em std {
      year 2018,
      month 1,
      day 14,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Management of important adverse events associated with
 inotuzumab ozogamicin: expert panel review."
      },
      authors {
        names std {
          {
            name ml "Kebriaei P",
            affil str "University of Texas MD Anderson Cancer Center, Houston,
 TX, USA. pkebriae@mdanderson.org."
          },
          {
            name ml "Cutler C",
            affil str "Dana Farber Cancer Center, Boston, MA, USA."
          },
          {
            name ml "de Lima M",
            affil str "UH Cleveland Medical Center and Case Western Reserve
 University, Cleveland, OH, USA."
          },
          {
            name ml "Giralt S",
            affil str "Memorial Sloan Kettering, New York, NY, USA."
          },
          {
            name ml "Lee SJ",
            affil str "Fred Hutchinson Cancer Research Center, Seattle, WA,
 USA."
          },
          {
            name ml "Marks D",
            affil str "University Hospitals Bristol, Bristol, UK."
          },
          {
            name ml "Merchant A",
            affil str "University of Southern California, Los Angeles, CA, USA."
          },
          {
            name ml "Stock W",
            affil str "University of Chicago, Chicago, IL, USA."
          },
          {
            name ml "van Besien K",
            affil str "Weill Cornell Medical College, New York, NY, USA."
          },
          {
            name ml "Stelljes M",
            affil str "Universitatsklinikum Munster, Munster, Germany."
          }
        }
      },
      from journal {
        title {
          iso-jta "Bone Marrow Transplant.",
          ml-jta "Bone Marrow Transplant",
          issn "1476-5365",
          name "Bone marrow transplantation"
        },
        imp {
          date std {
            year 2018,
            month 4
          },
          volume "53",
          issue "4",
          pages "449-456",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2017,
                month 7,
                day 13
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2017,
                month 10,
                day 13
              }
            },
            {
              pubstatus revised,
              date std {
                year 2017,
                month 10,
                day 6
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 1,
                day 14,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2019,
                month 5,
                day 16,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2018,
                month 1,
                day 14,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29330398,
        doi "10.1038/s41409-017-0019-y",
        pii "10.1038/s41409-017-0019-y",
        other {
          db "pmc",
          tag str "PMC5897380"
        },
        other {
          db "ELocationID doi",
          tag str "10.1038/s41409-017-0019-y"
        }
      }
    },
    mesh {
      {
        term "Antibodies, Monoclonal, Humanized",
        qual {
          {
            mp TRUE,
            subh "adverse effects"
          }
        }
      },
      {
        term "Clinical Trials as Topic"
      },
      {
        term "Disease Management"
      },
      {
        term "Febrile Neutropenia",
        qual {
          {
            subh "chemically induced"
          },
          {
            subh "diagnosis"
          },
          {
            subh "prevention & control"
          },
          {
            subh "therapy"
          }
        }
      },
      {
        term "Hepatic Veno-Occlusive Disease",
        qual {
          {
            subh "chemically induced"
          },
          {
            subh "diagnosis"
          },
          {
            subh "prevention & control"
          },
          {
            subh "therapy"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Inotuzumab Ozogamicin"
      },
      {
        term "Practice Guidelines as Topic"
      },
      {
        term "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        qual {
          {
            subh "complications"
          },
          {
            mp TRUE,
            subh "drug therapy"
          }
        }
      },
      {
        term "Risk Factors"
      },
      {
        term "Salvage Therapy",
        qual {
          {
            mp TRUE,
            subh "adverse effects"
          },
          {
            subh "methods"
          }
        }
      },
      {
        term "Tumor Lysis Syndrome",
        qual {
          {
            subh "diagnosis"
          },
          {
            subh "etiology"
          },
          {
            subh "prevention & control"
          },
          {
            subh "therapy"
          }
        }
      },
      {
        term "Vascular Diseases",
        qual {
          {
            subh "chemically induced"
          },
          {
            subh "diagnosis"
          },
          {
            subh "prevention & control"
          },
          {
            subh "therapy"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Antibodies, Monoclonal, Humanized"
      },
      {
        type cas,
        cit "P93RUU11P7",
        name "Inotuzumab Ozogamicin"
      }
    },
    xref {
    },
    pmid 29330398,
    pub-type {
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    },
    status medline
  }
}


